Form 8-K - Current report:
SEC Accession No. 0001004878-11-000339
Filing Date
2011-10-06
Accepted
2011-10-06 16:26:04
Documents
5
Period of Report
2011-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K RE CHARDAN form8krechardan10-11.txt 8-K 4182
2 EXHIBIT 5 form8kchardanexh510-11.txt EX-5 2469
3 EXHIBIT 10(AA) form8kchardanexh10aa10-11.txt EX-10 172238
4 EXHIBIT 10(BB) form8kchardanexh10bb10-11.txt EX-10 67021
5 EXHIBIT 23(A) form8kchardanexh23a10-11.txt EX-23 883
  Complete submission text file 0001004878-11-000339.txt   248016
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 111129681
SIC: 2836 Biological Products, (No Diagnostic Substances)